Every person interacts closely with various microorganisms that surround them and inhabit specific ecological niches on the body’s surfaces and within the organism, forming what we know as the normal microbiota (often called the normal microflora). In general, microbiota refers to the collection of all microorganisms residing within a multicellular organism, whether plant, animal, or human. From a taxonomic standpoint, these microorganisms include viruses, bacteria, archaea, microscopic fungi, and protozoa. Currently, bacteria are the best-studied representatives of human microbiota.
In the past decade, significant advancements in genomic research methods and technologies have enabled large-scale international projects focused on studying human microbiota, such as the Human Microbiome Project (HMP), the Integrative Human Microbiome Project (iHMP, USA), and the METAgenomics of the Human Intestinal Tract (MetaHIT, Europe).
These studies have greatly expanded our understanding of the species diversity and quantitative composition of microbiota across various human tissues and organs. Researchers have discovered that bacteria are not only present on the surface of the skin and mucous membranes but also exist in the bloodstream, in different solid organs and human tissues, and, under certain conditions, even within cells.
Human organs and systems previously considered sterile—such as the lungs, uterus, mammary glands, and even the fetus in the womb—have been found to contain their own microbiota. This microbiota influences their development and is crucial for their function and inter-system communication within the body.
Today, microbiota is considered a distinct and powerful “metabolic organ”, impacting the function of various organs and systems in the body through unique molecular mechanisms.
It is becoming increasingly clear that developing a complex, “healthy” microbiota is essential for maintaining a high quality of life at any age. Scientifically validated approaches are now being developed to help achieve this. Of particular interest is the potential to influence and correct microbiota composition through probiotics, prebiotics, and synbiotics.
This topic has garnered significant attention among gynecologists.
On October 25–26, 2024, the company "Ananta Medicare Ukraine" participated in a two-day online masterclass titled "Preconception – Standards and Updated Guidelines," led by Dr. Viktor Oshovsky, an obstetrician-gynecologist of the highest category, fetal medicine specialist, and practitioner at "Uniclinic" Medical Center in Kyiv.
In the session on "Optimization of Intestinal and Genital Tract Flora," Dr. Oshovsky emphasized the importance of women taking the probiotic Florium-A throughout life and during pregnancy, focusing on the simultaneous restoration of both intestinal and vaginal microflora. He highlighted the importance of both the quality and diversity of lactobacilli strains.
A separate topic addressed was vaginal candidiasis, a condition that almost every woman experiences at least once in her life and which often occurs during pregnancy. Dr. Oshovsky provided examples illustrating the need for Femifucin in cases of vaginitis caused by Candida albicans.
Florium-A! Smart flora! Simultaneous restoration of intestinal and vaginal microflora in women.
5 strains, 11 billion. CFU of lactobacilli in one capsule. 28 capsules per pack - for 2 weeks.
Femifucin is a vaginal pessary No.3 for topical use.
A large number of yeasts, yeast-like organisms, dermatophytes, and fungi are sensitive to Femifucin. It is a fungicidal agent with a high safety profile.
